Rathbones Group’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-8,519
Closed -$614K 634
2024
Q4
$614K Hold
8,519
﹤0.01% 387
2024
Q3
$681K Hold
8,519
﹤0.01% 372
2024
Q2
$610K Hold
8,519
﹤0.01% 380
2024
Q1
$600K Sell
8,519
-3,767
-31% -$270K ﹤0.01% 386
2023
Q4
$948K Buy
12,286
+6,745
+122% +$444K 0.01% 322
2023
Q3
$377K Sell
5,541
-4,961
-47% -$392K ﹤0.01% 444
2023
Q2
$857K Sell
10,502
-13,858
-57% -$1.11M 0.01% 257
2023
Q1
$1.81M Sell
24,360
-3,200
-12% -$247K 0.02% 211
2022
Q4
$2.28M Sell
27,560
-1,960
-7% -$156K 0.03% 196
2022
Q3
$2.1M Sell
29,520
-3,600
-11% -$311K 0.03% 198
2022
Q2
$2.87M Buy
33,120
+5,760
+21% +$540K 0.03% 188
2022
Q1
$2.96M Buy
+27,360
New +$2.82M 0.03% 189

Other funds holding TECH

Rathbones Group's TECH Position: Q1 2025 in Review

Rathbones Group sold out of Bio-Techne (TECH) in Q1 2025, closing a stake of 8,519 shares — an estimated $614K sold.

Rathbones Group first reported a position in TECH in Q1 2022 and held it in 12 quarters. The position peaked at $2.96M in Q1 2022. 578 funds tracked by Wall St. Rank hold TECH as of Q1 2025.

  • Rathbones Group reported no remaining Bio-Techne position as of Q1 2025 after selling out during the quarter.
  • Rathbones Group sold 8,519 Bio-Techne shares in Q1 2025, an estimated $614K.
  • Rathbones Group first reported a position in Bio-Techne in Q1 2022 and held it in 12 quarters.
  • Rathbones Group's Bio-Techne position peaked at $2.96M in Q1 2022.
  • 578 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2025.

Based on Rathbones Group's 13F filing for Q1 2025, filed 13 May 2025.